Global API Intermediates Market – Industry Trends and Forecast to 2028

  • Pharmaceutical
  • Published Report
  • Apr 2021
  • Global
  • 350 Pages
  • No of Tables: 319
  • No of Figures: 80

Global API Intermediates Market, By Type (Veterinary Drug Intermediates, Pharmaceutical / Bulk Drug Intermediates), Product (Bromo Compound, O-Benzyl Salbutamol, Hemisulfate, Oxirane, Bisoprolol Base, Chiral PCBHP, Pheniramine Base, Chlorpheniramine Base, Brompheniramine Base, Mepyramine/Pyrilamine Base, 6-Amino-1,3-Dimethyl Uracil, Theofylline, Acefylline, Xanthine, Nitriles, Others), Therapeutic Type (Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Cardiovascular Diseases, Infectious Diseases, Neurology, Respiratory Disorders, Dermatology, Urology, Others), Customers (Direct Users/Pharma Companies, Traders/Wholesalers/Distributors, Associations/Govt. Institutions/Pvt Institutions), End User (API Manufacturer, Finished Product Manufacturer), Distribution Channel (Direct Tender, Retail Sales, Others), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe, Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt and Rest of Middle East and Africa) Industry Trends and Forecast to 2028      

API Intermediates Market

Market Analysis and Insights: Global API Intermediates Market

The API intermediates market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.4% in the forecast period of 2021 to 2028 and is expected to reach USD 37,423.56 million by 2028. High burden of chronic diseases is acting as a driver for growing the demand of global API intermediates market.

Active pharmaceutical ingredients are the substance or combination of substances intended to be used in the manufacturing of a drug product which when used in the production of the drug, becomes an active pharmaceutical ingredient. Such substances are used to provide pharmacological activity.

Utilization of advanced technology in API and intermediates manufacturing is acting as a driver for boosting the demand of the global API intermediates market. Stringent government regulations for API intermediates are acting as a restraint for hampering the demand of the global API intermediates market. Rise in number of contract manufacturing organizations (CDMO) and contract research organizations (CMO) will further increase the growth opportunities for the global API intermediates market. Disruption in the supply chain of API intermediates due to COVID-19 acts challenging for the healthcare providers which may challenge the global API intermediates market.

The API intermediates market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the API intermediates market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

API Intermediates Market

API Intermediates Market Scope and Market Size

The API intermediates market is segmented on the basis of the type, product, therapeutic class, customers, end users and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of type, the API intermediates market is segmented into veterinary drug intermediates and pharmaceutical / bulk drug intermediates. In 2021, pharmaceutical / bulk drug intermediates segment is expected to dominate the API intermediates market due to the rising demand of APIs for the production of finished goods and rising prevalence of various diseases which required continuous production of drugs.
  • On the basis of product, the API intermediates market is segmented into bromo compound, O-benzyl salbutamol, hemisulfate, oxirane, bisoprolol base, chiral PCBHP, pheniramine base, chlorpheniramine base, brompheniramine base, mepyramine/pyrilamine base, 6-amino-1,3-dimethyl uracil, theofylline, acefylline, xanthine, nitriles and others. In 2021, nitriles segment is expected to dominate the API intermediates market due to the high cost of the products and continued research and development for the innovative APIs.
  • On the basis of therapeutic type, the API intermediates market is segmented into autoimmune diseases, oncology, metabolic diseases, ophthalmology, cardiovascular diseases, infectious diseases, neurology, respiratory disorders, dermatology, urology and others. In 2021, cardiovascular diseases segment is expected to dominate the API intermediates market because cardiovascular is the leading cause of death globally.
  • On the basis of customers, the API intermediates market is segmented into direct users/pharma companies, traders/wholesalers/distributors and associations/govt. institutions/Pvt institutions. In 2021, direct users/pharma companies segment is expected to dominate the API intermediates market because APIs manufacturers are the primary and direct user for the intermediates.
  • On the basis of end user, the API intermediates market is segmented into API manufacturer and finished product manufacturer. In 2021, API manufacturer segment is dominating the API intermediates market because intermediates are the primary chemical substrate of the APIs which can be further converted in APIs.
  • On the basis of distribution channel, the API intermediates market is segmented into direct tender, retail sales and others. In 2021, direct tender segment is expected to dominate the API intermediates market because direct tender provides huge margin for the purchase of good and direct tender has competitive selection of contract and consultants accountability.

API Intermediates Market

Global API Intermediates Market Country Level Analysis

Global API intermediates market is analyzed and market size information is provided on the basis of the country, type, product, therapeutic type, customers, end user and distribution channel as referenced above.  

The countries covered in the global API intermediates market report are the U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, rest of Europe, Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, rest of Asia-Pacific, Brazil, Argentina, Peru, rest of South America, Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt and rest of Middle East and Africa.

The U.S. is dominating in the North America API intermediates market and is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 because of increasing healthcare expenditure and well-established healthcare infrastructure for the pharmaceutical / bulk drug intermediates segment. China is leading the growth of the Asia-Pacific API intermediates market and pharmaceutical / bulk drug intermediates segment is dominating in the country due to increase in availability of API intermediates at lower cost. The pharmaceutical / bulk drug intermediates segment in Germany is dominating in the Europe API intermediates market owing to increasing consumption demand for the API intermediates.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

High Burden of Chronic Diseases is boosting the API Intermediates Market Growth

The API intermediates market also provides you with detailed market analysis for every country growth in API intermediates industry with API intermediates sales, impact of advancement in the API intermediates technology and changes in regulatory scenarios with their support for the API intermediates market. The data is available for historic period 2011 to 2019.

Competitive Landscape and API Intermediates Market Share Analysis

The API intermediates market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to global API intermediates market.

The major companies covered in the global API intermediates market report are HIKAL Ltd., Cambrex Corporation, Ganesh-Group, AlzChem Group AG, Vasudha Pharma, Anyang General Chemical Co.,Ltd., Sarex, Sandoo Pharmaceuticals and Chemicals Co., Ltd., Atul Ltd, Sandoz International GmbH (a subsidiary of Novartis AG), Aceto, Supriya Lifescience Ltd., LEVACHEM COMPANY LIMITED, Vertellus, Dishman Carbogen Amcis Ltd, Sanofi, Divi's Laboratories Limited, AARTI INDUSTRIES LIMITED, Aurobindo Pharma and BASF SE among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launches and agreements are also initiated by the companies’ worldwide which are also accelerating the API intermediates market.

For instance,

  • In January 2021, Vertellus has been acquired by the company, Pritzker Private Capital who partners with the middle-market companies established in North America and builds up the long-term relationship with that company. As Vertellus is considered as leading company or provider of specialty chemicals in different sectors such as healthcare, food & agriculture, personal care, transportation and coatings, so PPC has made a partnership with the company. This helped the company Vertellus to increase their market growth which will drive revenues of the company.

Collaboration, product launch, business expansion, award and recognition, joint ventures and other strategies by the market players is enhancing the company market in the API intermediates market which also provides the benefit for organization to improve their offering for API intermediates.

Customization Available: Global API Intermediates Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.


SKU-

TABLE 1 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS INTERMEDIATES: CUSTOMIZATION (COUNTRIES INVOLVED IN IMPORT & EXPORT)

TABLE 2 PERCENTAGE BREAK UP OF COST

TABLE 3 TENTATIVE LAND REQUIREMENT

TABLE 4 PERCENTAGE BREAK UP OF PLANT AREA

TABLE 5 TABLE: 1 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS INTERMEDIATES: LIST OF API OR FORMULATION COMPANIES WITH API INTERMEDIATE

TABLE 6 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC

TABLE 7 MARKET PLAYERS OF API INTERMEDIATES

TABLE 8 SALES DATA OF API INTERMEDIATES FOR 2019/2020

TABLE 9 GLOBAL API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 10 GLOBAL PHARMACEUTICAL INTERMEDIATES/ BULK DRUG INTERMEDIATES IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 11 GLOBAL VETERINARY DRUG INTERMEDIATES IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 12 GLOBAL API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 13 GLOBAL NITRILES IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 14 GLOBAL BROMO COMPOUND IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 15 GLOBAL CHIRAL PCBHP IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 16 GLOBAL CHLORPHENIRAMINE BASE IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 GLOBAL BROMPHENIRAMINE BASE IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 GLOBAL PHENIRAMINE BASE IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 19 GLOBAL O-BENZYL SALBUTAMOL IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 GLOBAL BISOPROLOL BASE IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 GLOBAL HEMISULFATE IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 GLOBAL OXIRANE IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 GLOBAL MEPYRAMINE/PYRILAMINE BASE IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 GLOBAL THEOFYLLINE IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 25 GLOBAL ACEFYLLINE IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 GLOBAL XANTHINE IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 GLOBAL 6-AMINO-1, 3-DIMETHYL URACIL IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 GLOBAL OTHERS IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 GLOBAL API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 30 GLOBAL CARDIOVASCULAR DISEASES IN API INTERMEDIATES MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 31 GLOBAL METABOLIC DISEASES IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 GLOBALINFECTIOUS DISEASES IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 33 GLOBAL RESPIRATORY DISEASES IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 34 GLOBAL NEUROLOGY IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 35 GLOBAL ONCOLOGY IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 36 GLOBAL AUTOIMMUNE DISEASES IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 37 GLOBAL DERMATOLOGY IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 38 GLOBAL OPHTHALMOLOGY IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 39 GLOBAL UROLOGY IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 40 GLOBAL OTHERS IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 41 GLOBAL API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 42 GLOBAL DIRECT USERS/PHARMA COMPANIES IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 43 GLOBAL TRADERS/WHOLESALERS/DISTRIBUTORS IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 44 GLOBAL ASSOCIATIONS/GOVT. INSTITUTIONS/PVT INSTITUTIONSIN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 45 GLOBAL API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 46 GLOBAL API MANUFACTURER IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 47 GLOBAL FINISHED PRODUCT MANUFACTURER IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 48 GLOBAL API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 49 GLOBAL DIRECT TENDER IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 50 GLOBAL RETAIL SALES IN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 51 GLOBAL OTHERSIN API INTERMEDIATES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 52 GLOBAL ACTIVE PHARAMCEUTICAL INGREDIENTS MARKET, BY REGION , 2021-2028 (USD MILLION)

TABLE 53 NORTH AMERICA API INTERMEDIATES MARKET, BY COUNTRY, 2018-2028 (USD MILLION)

TABLE 54 NORTH AMERICA API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 55 NORTH AMERICA API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 56 NORTH AMERICA API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 57 NORTH AMERICA API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 58 NORTH AMERICA API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 59 NORTH AMERICA API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 60 U.S API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 61 U.S API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 62 U.S API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 63 U.S API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 64 U.S API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 65 U.S API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 66 CANADA API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 67 CANADA API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 68 CANADA API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 69 CANADA API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 70 CANADA API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 71 CANADA API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 72 MEXICO API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 73 MEXICO API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 74 MEXICO API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 75 MEXICO API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 76 MEXICO API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 77 MEXICO API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 78 EUROPE API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 79 EUROPE API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 80 EUROPE API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 81 EUROPE API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 82 EUROPE API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 83 EUROPE API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 84 EUROPE API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 85 GERMANY API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 86 GERMANY API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 87 GERMANY API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 88 GERMANY API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 89 GERMANY API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 90 GERMANY API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 91 U.K API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 92 U.K API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 93 U.K API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 94 U.K API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 95 U.K API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 96 U.K API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 97 U.K API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 98 ITALY API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 99 ITALY API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 100 ITALY API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 101 ITALY API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 102 ITALY API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 103 SPAIN API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 104 SPAIN API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 105 SPAIN API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 106 SPAIN API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 107 SPAIN API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 108 SPAIN API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 109 FRANCE API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 110 FRANCE API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 111 FRANCE API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 112 FRANCE API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 113 FRANCE API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 114 FRANCE API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 115 NETHERLANDS API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 116 NETHERLANDS API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 117 NETHERLANDS API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 118 NETHERLANDS API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 119 NETHERLANDS API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 120 NETHERLANDS API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 121 RUSSIA API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 122 RUSSIA API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 123 RUSSIA API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 124 RUSSIA API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 125 RUSSIA API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 126 RUSSIA API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 127 SWITZERLAND API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 128 SWITZERLAND API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 129 SWITZERLAND API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 130 SWITZERLAND API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 131 SWITZERLAND API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 132 SWITZERLAND API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 133 TURKEY API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 134 TURKEY API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 135 TURKEY API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 136 TURKEY API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 137 TURKEY API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 138 TURKEY API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 139 AUSTRIA API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 140 AUSTRIA API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 141 AUSTRIA API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 142 AUSTRIA API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 143 AUSTRIA API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 144 AUSTRIA API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 145 NORWAY API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 146 NORWAY API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 147 NORWAY API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 148 NORWAY API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 149 NORWAY API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 150 NORWAY API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 151 HUNGARY API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 152 HUNGARY API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 153 HUNGARY API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 154 HUNGARY API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 155 HUNGARY API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 156 HUNGARY API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 157 LITHUANIA API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 158 LITHUANIA API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 159 LITHUANIA API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 160 LITHUANIA API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 161 LITHUANIA API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 162 LITHUANIA API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 163 IRELAND API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 164 IRELAND API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 165 IRELAND API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 166 IRELAND API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 167 IRELAND API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 168 IRELAND API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 169 POLAND API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 170 POLAND API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 171 POLAND API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 172 POLAND API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 173 POLAND API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 174 POLAND API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 175 REST OF ASIA PACIFIC API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 176 ASIA-PACIFIC API INTERMEDIATES MARKET, BY COUNTRY, 2018-2028 (USD MILLION)

TABLE 177 ASIA-PACIFIC API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 178 ASIA-PACIFIC API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 179 ASIA-PACIFIC API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 180 ASIA-PACIFIC API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 181 ASIA-PACIFIC API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 182 ASIA-PACIFIC API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 183 CHINA API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 184 CHINA API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 185 CHINA API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 186 CHINA API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 187 CHINA API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 188 CHINA API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 189 INDIA API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 190 INDIA API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 191 INDIA API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 192 INDIA API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 193 INDIA API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 194 INDIA API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 195 INDIA API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 196 JAPAN API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 197 JAPAN API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 198 JAPAN API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 199 JAPAN API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 200 JAPAN API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 201 AUSTRALIA API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 202 AUSTRALIA API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 203 AUSTRALIA API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 204 AUSTRALIA API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 205 AUSTRALIA API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 206 AUSTRALIA API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 207 SOUTH KOREA API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 208 SOUTH KOREA API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 209 SOUTH KOREA API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 210 SOUTH KOREA API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 211 SOUTH KOREA API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 212 SOUTH KOREA API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 213 SINGAPORE API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 214 SINGAPORE API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 215 SINGAPORE API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 216 SINGAPORE API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 217 SINGAPORE API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 218 SINGAPORE API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 219 MALAYSIA API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 220 MALAYSIA API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 221 MALAYSIA API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 222 MALAYSIA API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 223 MALAYSIA API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 224 MALAYSIA API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 225 THAILAND API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 226 THAILAND API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 227 THAILAND API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 228 THAILAND API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 229 THAILAND API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 230 THAILAND API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 231 INDONESIA API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 232 INDONESIA API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 233 INDONESIA API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 234 INDONESIA API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 235 INDONESIA API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 236 INDONESIA API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 237 PHILIPPINES API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 238 PHILIPPINES API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 239 PHILIPPINES API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 240 PHILIPPINES API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 241 PHILIPPINES API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 242 PHILIPPINES API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 243 VIETNAM API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 244 VIETNAM API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 245 VIETNAM API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 246 VIETNAM API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 247 VIETNAM API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 248 VIETNAM API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 249 REST OF ASIA PACIFIC API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 250 SOUTH AMERICA API INTERMEDIATES MARKET, BY COUNTRY, 2018-2028 (USD MILLION)

TABLE 251 SOUTH AMERICA API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 252 SOUTH AMERICA API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 253 SOUTH AMERICA API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 254 SOUTH AMERICA API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 255 SOUTH AMERICA API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 256 SOUTH AMERICA API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 257 BRAZIL API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 258 BRAZIL API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 259 BRAZIL API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 260 BRAZIL API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 261 BRAZIL API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 262 BRAZIL API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 263 ARGENTINA API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 264 ARGENTINA API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 265 ARGENTINA API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 266 ARGENTINA API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 267 ARGENTINA API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 268 ARGENTINA API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 269 PERU API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 270 PERU API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 271 PERU API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 272 PERU API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 273 PERU API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 274 PERU API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 275 REST OF SOUTH AMERICA API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 276 MIDDLE EAST & AFRICA API INTERMEDIATES MARKET, BY COUNTRY, 2018-2028 (USD MILLION)

TABLE 277 MIDDLE EAST & AFRICA API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 278 MIDDLE EAST & AFRICA API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 279 MIDDLE EAST & AFRICA API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 280 MIDDLE EAST & AFRICA API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 281 MIDDLE EAST & AFRICA API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 282 MIDDLE EAST & AFRICA API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 283 SAUDI ARABIA API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 284 SAUDI ARABIA API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 285 SAUDI ARABIA API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 286 SAUDI ARABIA API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 287 SAUDI ARABIA API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 288 SAUDI ARABIA API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 289 SOUTH AFRICA API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 290 SOUTH AFRICA API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 291 SOUTH AFRICA API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 292 SOUTH AFRICA API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 293 SOUTH AFRICA API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 294 SOUTH AFRICA API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 295 UAE API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 296 UAE API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 297 UAE API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 298 UAE API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 299 UAE API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 300 UAE API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 301 ISRAEL API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 302 ISRAEL API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 303 ISRAEL API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 304 ISRAEL API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 305 ISRAEL API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 306 ISRAEL API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 307 KUWAIT API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 308 KUWAIT API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 309 KUWAIT API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 310 KUWAIT API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 311 KUWAIT API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 312 KUWAIT API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 313 EGYPT API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 314 EGYPT API INTERMEDIATES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 315 EGYPT API INTERMEDIATES MARKET, BY THERAPEUTIC TYPE, 2019-2028 (USD MILLION)

TABLE 316 EGYPT API INTERMEDIATES MARKET, BY CUSTOMERS, 2019-2028 (USD MILLION)

TABLE 317 EGYPT API INTERMEDIATES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 318 EGYPT API INTERMEDIATES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 319 REST OF MIDDLE EAST & AFRICA API INTERMEDIATES MARKET, BY TYPE, 2019-2028 (USD MILLION)

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions